Aurore Pharmaceuticals Private Limited, a active private limited company, was established on 15 May 2017 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2017PTC117032. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹42.11 Cr.
Formerly known as Sphery Lifesciences Private Limited. It upholds a compliant status. Employing 451 professional, Its leadership includes Sareddy Reddy Ravisankara (Nominee Director), Sailesh Jhawar Kumar (Director). Past directors included Vamsilatha Thulasi, Dayakar Reddy Mallu, Allada Trisha. It holds ₹320.00 Cr open charges and ₹2.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot # 68,69, 2Nd Floor, Jubilee Heights Beside Shilparamam, Madhapur, Hyderabad, Telangana, 500081.
U24239TG2017PTC117032
117032
15 May 2017
₹50.00 Cr
₹42.11 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aurore Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sareddy Reddy Ravisankara | Nominee Director | 06 Dec 2022 | Current |
| Sailesh Jhawar Kumar | Director | 18 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 04 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2018 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 04 Jan 2023 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2021 | Past |
| Pramod Abcsdd | Director | 15 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurore Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 133.38% increase. The company also saw a substantial fall in profitability, with a 71.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Aurore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,200,000,000.00
₹25,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2024 | Others | ₹300.00 Cr | Open |
| 29 May 2018 | Yes Bank Limited | ₹20.00 Cr | Open |
| 15 Jun 2018 | Axis Bank Limited | ₹2.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Aurore Pharmaceuticals has a workforce of 451 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurore Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 15 Jun 2018 via Charge ID 100198200 with Axis Bank Limited was fully satisfied on 03 Jun 2025. was documented.
Progress on Pooja Toshniwal was appointed as a Company Secretary was appointed as a Company Secretary on 06 Jan 2025 & has been associated with this company since 11 months 9 days . was documented.
A charge with Others of Rs. 300.00 Cr registered on 26 Sep 2024 with Charge ID 101017337 was modified on 19 Nov 2024. was recorded as a recent event.
The activity A charge with Axis Bank Limited of Rs. 2.50 Cr registered on 15 Jun 2018 with Charge ID 100198200 was modified on 30 Oct 2024. was completed.
Progress on A charge with Yes Bank Limited of Rs. 20.00 Cr registered on 29 May 2018 with Charge ID 100197941 was modified on 30 Oct 2024. was documented.
Progress on Aurore Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Aurore Pharmaceuticals Private Limited is U24239TG2017PTC117032.
Aurore Pharmaceuticals Private Limited is headquartered at Plot # 68,69, 2Nd Floor, Jubilee Heights Beside Shilparamam, Madhapur, Hyderabad, Telangana, 500081.
Aurore Pharmaceuticals Private Limited was incorporated on 15 May 2017.
The current directors of Aurore Pharmaceuticals Private Limited are
The primary industry of Aurore Pharmaceuticals Private Limited is Manufacturing.
Aurore Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aurore Pharmaceuticals Private Limited is ₹50.00 Cr, and the paid-up capital is ₹42.11 Cr.
The compliance status of Aurore Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX